KDM4B and cancer: Notably, in the TCGA pan‐cancer database, samples exhibiting low KDM4B expression displayed elevated levels of IFN‐β, CXCL10, ISG15, PD‐L1 and PD‐1, in contrast to those with high KDM4B expression (Figure 7C–E).